Judy C. Boughey - Concepedia

Author

Judy C. Boughey

Also Known As

Anne Blaes, Ballman, Karla V., Boughey, Judy, Boughey, Judy C, Boughey, Judy C., Hunt, Kelly K., ISPY-2 Locoregional Working Group, J Boughey, J C Boughey, J. Boughey

827

Publications

23.7K

Citations

H-Index

166

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic Mayo Clinic in Florida The University of Texas MD Anderson Cancer Center WinnMed

About

Judy C. Boughey is an author at Mayo Clinic in Arizona specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	54	160	8.2K
2	Health Sciences	24	42	2.1K
3	Nursing	8	8	378
4	Public Health	7	7	464
5	Engineering	4	4	510

Judy C. Boughey

289

Publications

20.6K

Citations

H-Index

Page 1

	Year	Citations
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer Judy C. Boughey JAMA	2013	1.5K
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer Rita Nanda, Minetta C. Liu, Christina Yau, JAMA Oncology	2020	672
Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele, New England Journal of Medicine	2016	543
Adaptive Randomization of Neratinib in Early Breast Cancer John W. Park, Minetta C. Liu, Douglas Yee, New England Journal of Medicine	2016	453
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy Judy C. Boughey, Karla V. Ballman, Huong T. Le‐Petross, Annals of Surgery	2015	441
Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Judy C. Boughey, Linda McCall, Karla V. Ballman, Annals of Surgery	2014	419
Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging Rajini Katipamula, Amy C. Degnim, Tanya L. Hoskin, Journal of Clinical Oncology	2009	371
Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons Eric R. Manahan, Henry M. Kuerer, Molly Sebastian, Annals of Surgical Oncology	2019	319
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline Nadine Tung, Judy C. Boughey, Lori J. Pierce, Journal of Clinical Oncology	2020	307
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial Lajos Pusztai, Christina Yau, Denise M. Wolf, Cancer Cell I-spy2 TrialBreast OncologyMedicinePharmacologyImmune Checkpoint Inhibitor	2021	300

Page 1